🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

IAN Group backs Chargeup in Rs 22 Cr funding round

EntrackrEntrackr · 27d ago
IAN Group backs Chargeup in Rs 22 Cr funding round
Medial

IAN Group backs Chargeup in Rs 22 Cr funding round EV-focused mobility startup Chargeup has raised Rs 22 crore ($2.4 million) in a funding round backed by IAN Group, along with Cap-A and existing investors. The new round came after a gap of four years. This is the third funding round for the Delhi-based startup. In November 2022, the firm had raised $7 million in a pre-Series A1 round led by Capital-A and Anicut Capital. In the same year, it raised $2.3 million in its pre-Series A round led by Capital-A and co-led by Anicut Capital. The proceeds will be used to expand into high-demand EV markets, strengthen its technology platform for drivers and lenders, and scale operations across regions with rising electric three-wheeler adoption. Founded in 2019 by Varun Goenka and Satish Mittal, Chargeup is building a driver-first EV technology platform focused on last-mile drivers. The platform addresses challenges such as high financing costs, battery-related downtime, and income loss, which significantly impact earnings for EV three-wheeler drivers. Chargeup integrates IoT and data-led tools to reduce lending risk for NBFCs while improving earning stability, vehicle utilization, and resale value for drivers. The platform connects drivers, OEMs, dealers, and lenders within a single system. The startup has onboarded over 10,000 EV drivers and plans to add another 20,000 drivers by FY27. It operates in a market estimated at $12 billion, driven by increasing adoption of electric three-wheelers across logistics and passenger mobility.

e-TRNL Energy raises Rs 27.4 Cr seed round led by IAN Group

EntrackrEntrackr · 5d ago
e-TRNL Energy raises Rs 27.4 Cr seed round led by IAN Group
Medial

e-TRNL Energy raises Rs 27.4 Cr seed round led by IAN Group Battery cell technology startup e-TRNL Energy has raised Rs 27.4 crore (around $3 million) in a seed funding round led by IAN Group through its IAN Alpha Fund. The round also saw participation from Navam Capital, Speciale Invest, and other investors. The proceeds will be used to complete product development, validate performance and safety, and demonstrate manufacturing capability in India. Founded in 2021 by Apoorv Shaligram and Dr. Uttam Kumar Sen, e-TRNL Energy is developing next-generation battery cell technology focused on redesigning core cell architecture and manufacturing processes. The startup has established a 20,000 sq. ft. R&D and early manufacturing facility in Bengaluru. It has been granted two patents and has filed additional patent applications. e-TRNL plans to set up a 250 MWh pilot manufacturing facility by 2027, with plans to scale to 2 GWh capacity later. Its first product will use LFP (Lithium Iron Phosphate) chemistry, with future development planned for LMFP and sodium-ion batteries.

MiClient raises seed round from IAN Group, others

EntrackrEntrackr · 1y ago
MiClient raises seed round from IAN Group, others
Medial

MiClient, an AI-driven B2B sales enablement platform, has raised Rs 3.9 crore in its seed funding round led by IAN Group with participation from Anicut, GSF, RTAF, and Keiretsu. Vikas Kuthiala and Pratik Mathurkar from IAN led the round. The round follows an initial pre-seed investment in October 2023 from 100x.VC. The proceeds will be used to build a stronger team and expand market presence across more geographies in India. In addition to market expansion, MiClient is developing an AI-based model to create quotations and invoices in seconds, further streamlining the sales process for its users. Led by Swati Sharma, MiClient’s easy-to-use CPQ platform helps sales teams close deals three times faster, with the average deal now closing in just 10 days. Expanding further into India’s industrial hubs, MiClient is executing a feet-on-the-street go-to-market strategy. MiClient is expanding into more industrial hubs across India using a direct sales approach. With over 150 customers and over 1,500 users, the company serves SMEs, particularly in the B2B manufacturing sector, with a user-friendly platform.

Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group

EntrackrEntrackr · 7m ago
Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group
Medial

Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group Lamark's proprietary ProteoStrong platform enables the stabilization of fragile protein-based drugs, such as insulin, monoclonal antibodies, and enzymes, without altering their molecular structure. Biopharma startup Lamark Biotech has raised Rs 6.5 crore in a pre-Series A round led by IAN Group, including IAN Alpha Fund, powered by BioAngels, Vinayender Tulla, Nita Roy, and Venkataraman KNK. Domain experts from IAN’s angel investors led the round. The Ahmedabad-based company had previously raised $41.3K in a seed funding round led by VIT-TBI and others. The fresh funds will be utilized to accelerate the development of thermostable insulin and expand the biologics platform for global access, Lamark said in a press release. Founded in 2018 by Vaibhav Bhatia, Lamark Biotech aims to reimagine drug delivery for chronic and life-altering diseases. Its proprietary ProteoStrong platform enables the stabilization of fragile protein-based drugs, such as insulin, monoclonal antibodies, and enzymes, without altering their molecular structure. According to Lamark Biotech, it leverages the R&D base of Venture Center, NCL Innovation, and it is advancing a new class of temperature-resilient biologics that retain potency across extreme conditions—ideal for underserved regions where cold storage infrastructure is limited. With its lead program, InsulinStrong, Lamark is targeting the Rs 4,000 crore Indian insulin market and intends to expand across Southeast Asia and the UAE. In the next 24 months, it plans to file new international patents, begin early clinical trials, and build partnerships with pharma companies, CDMOs, and global health agencies.

Download the medial app to read full posts, comements and news.